Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
about
Pancreatic Cancer GeneticsGenetics and biology of pancreatic ductal adenocarcinomaFamilial Pancreatic AdenocarcinomaIs it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control StudyHereditary pancreatic cancer: related syndromes and clinical perspective.Counselling framework for moderate-penetrance cancer-susceptibility mutations.CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts.Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition.Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer.Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank.Expression of PTEN and KAI1 tumor suppressor genes in pancreatic carcinoma and its association with different pathological factors.Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer PatientsSingle agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerGenetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.Identification of germline genetic mutations in patients with pancreatic cancer.Germline mutations in Japanese familial pancreatic cancer patients.Current and future therapies for advanced pancreatic cancer.Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders.Advances in Hereditary Colorectal and Pancreatic Cancers.Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancerGermline mutations in pancreatic cancer and potential new therapeutic options.Comprehensive benchmarking of SNV callers for highly admixed tumor data.Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.Exome-Wide Association Study of Pancreatic Cancer Risk.Rare germline variants in known melanoma susceptibility genes in familial melanoma.Diagnosis and Management of Pancreatic Cystic Neoplasms.Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.Susceptibility of ATM-deficient pancreatic cancer cells to radiation.Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.Inherited pancreatic cancer.Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer.Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer.Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.
P2860
Q26765235-10620B77-2152-4DF3-8B13-EF6987C0270CQ26765438-AD295C9E-9079-4BD2-AA4C-C2553DD99E99Q26801415-9703BBE5-F249-4AE6-9EBC-76B42D439228Q28073673-1460BD14-1325-4B92-BF83-8E9663FB5E9DQ28392577-D5A25D97-CF8C-4C10-A248-356AC846C9EDQ33851085-B6ADB55F-29B6-4460-B1CA-7302BACC54B0Q33911135-24CAF750-1A78-4985-A1FA-D33A8C9CADBCQ35783549-811F5C30-00BE-4FB5-AF46-0A93CF85C61FQ35894302-3CAD2D9A-8355-42E0-A583-228A22690637Q35909611-ED1DB15B-86BA-4B86-A92D-6293F013750DQ35941554-BAA1FE9E-8ABE-47DD-ADB0-77123D884D01Q36098650-596BA489-0699-4192-8724-AB192F8132EAQ36197062-C825BC24-92AF-442E-9EC6-EACEE35AEB70Q36502768-F293FBEC-86CB-455D-AD97-B7D42E4FCCB5Q36581642-280091B8-9584-4239-84F1-D8FBA2969596Q36689024-F3D2EF85-1A45-4EA4-8EA6-746196616168Q36849670-9ADDDF94-180E-476A-92EB-E21BB8F657D9Q37540235-1046E7E9-D0AD-402D-A7A8-8E9858E68077Q37687547-5B623E71-FD7A-4C44-A7E2-57953F86789EQ38673621-9C40A100-48E2-4E25-A8CC-7CA1045AC797Q38750036-FB43CEE0-9467-427E-80AF-4F76D1DD9718Q38798530-46359660-E859-41AE-80D5-DF7F5E11E8D3Q39262474-3FE8EF4D-1A58-4207-BDF4-50AEF372ECF3Q39568294-0938F552-7845-4C1A-8B2D-C34B833EBCF6Q41322585-CD71E7E3-5FAF-4036-BA00-6847F920464EQ42700671-D669F40F-BB69-43FC-94BD-CD5B342E0282Q42705197-9FCF7BC2-642E-4344-A5B0-629690F41006Q47624692-6E4A4247-31C8-4375-BDAF-5FD625BE74A0Q47710148-713D85FE-4D40-470A-A7CB-716C349E6453Q47786373-5F906495-E90B-457E-9046-0725E39E8EE4Q47880483-91769BCC-AC1B-4E19-B1B3-0C71BDA8F4F2Q47950548-D6B568EB-B8E4-4725-84FC-8D065224E177Q48218378-5FBA8E59-CEA9-4691-AAF6-DA4BA7D3DE01Q49166530-71919692-828F-4C99-8E15-318324BA0019Q50146622-C5B60AD9-21E5-44CE-BB8D-E1C61ADA4893Q52579674-BB0CB0A3-13C8-4ED5-A974-892EA96AC035Q54277914-713B4293-692E-4926-B693-D26C17DE72F0Q54957880-4418999A-49F1-49F6-A5DE-4C31740431C5Q55059406-29C243A8-DF40-491B-BC6F-9E2E2D9CA615Q55104265-7F31D883-FA7A-48B1-ADAC-F93E28DA31B6
P2860
Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prevalence of germline mutatio ...... tients with pancreatic cancer.
@ast
Prevalence of germline mutatio ...... tients with pancreatic cancer.
@en
type
label
Prevalence of germline mutatio ...... tients with pancreatic cancer.
@ast
Prevalence of germline mutatio ...... tients with pancreatic cancer.
@en
prefLabel
Prevalence of germline mutatio ...... tients with pancreatic cancer.
@ast
Prevalence of germline mutatio ...... tients with pancreatic cancer.
@en
P2093
P2860
P1433
P1476
Prevalence of germline mutatio ...... atients with pancreatic cancer
@en
P2093
Ashton A Connor
Ayelet Borgida
Gloria M Petersen
Iris Selander
Jordan Lerner-Ellis
Laurent Briollais
Shamini Selvarajah
Spring Holter
P2860
P304
P356
10.1053/J.GASTRO.2014.11.042
P407
P577
2014-12-02T00:00:00Z